According to a recent study, liquid synthetic detergents are better suited for maintaining healthy skin barrier function in patients with atopic dermatitis (AD) than soaps.
Study shows most effective AD treatments may have greater risk of adverse events
According to a recent study, the most effective atopic dermatitis (AD) treatments may also have the greatest risk of adverse events.
Study suggests multidisciplinary approach best for difficult-to-control AD in youth
According to a recent study, a multidisciplinary approach using dermatologists, allergists and family members is most effective for treating difficult-to-control atopic dermatitis (AD) in children and adolescents.
Guselkumab shows significant scalp psoriasis clearance in skin of colour patients
According to a recent study, guselkumab has shown significant improvements in skin clearance, scalp itch, and patient-reported health-related quality of life in skin of colour patients with moderate-to-severe scalp psoriasis.
Study suggests multilevel changes may be needed to reduce impact of acne in trans patients
According to a recent study, multilevel changes may be needed to reduce the impact of acne-related stigma and barriers to acne treatment in transgender and gender-diverse individuals.
Study suggests high prevalence of HS in younger Finnish patients
According to a recent study, there is a high prevalence of hidradenitis suppurativa (HS) in Finland among patients in their 30s.
Early acne education may improve health literacy, treatment compliance
A recent medical student-led initiative has shown that early acne education can help improve acne health literacy and promote help-seeking behaviour.
Treatment options from dermatologists, other physicians differs in pediatric HS cases
According to a recent study, dermatologists are more likely than other physicians to prescribe standard of care therapies to pediatric hidradenitis suppurativa (HS) patients.
Study shows IL-23 inhibitors linked to lowest risk on paradoxical AD in PsO patients
According to a recent study, IL-23 inhibitors used to treat psoriasis patients are associated with the lowest risk of paradoxical atopic dermatitis (AD) compared to other biologics.
New AD guidelines published with updated treatments and recommendations
The American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force has published updated atopic dermatitis (AD) guidelines based on new available treatments and evidence-based recommendations.
HealthMinute.TV 